• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Charles A. Simonton - Articles and news items

Abbott logo

Abbott completes enrollment of Absorb™ randomized clinical trials in the United States, Japan and China

Industry news / 10 April 2014 / Abbott

Abbott announced it has completed enrollment of three clinical trials to support approvals of the company’s revolutionary Absorb™ Bioresorbable Vascular Scaffold…

Abbott logo

Abbott initiates randomized clinical trial in Japan to evaluate the Absorb™ Bioresorbable Vascular Scaffold

Industry news, News / 11 June 2013 / Abbott

Trial to study the innovative “dissolving” heart device…

Abbott logo
Abbott logo

Abbott announces CE Mark for world’s longest coronary drug eluting stent

Industry news, News / 21 May 2013 / Abbott

Abbott announced CE Mark in Europe for the XIENCE Xpedition™ 48 Everolimus Eluting Coronary Stent System…

Abbott logo
Abbott logo
Abbott logo

Abbott initiates clinical trial of Absorb™ in the United States

Industry news, News / 8 January 2013 / Abbott

Abbott announced the initiation of the ABSORB III clinical trial in patients in the United States…

Abbott logo

Abbott announces CE Mark and European launch of next-generation XIENCE Xpedition™ Drug Eluting Stent

Industry news, News / 20 August 2012 / Abbott

XIENCE Xpedition™ Everolimus Eluting Coronary Stent System receives CE Mark…

Abbott logo

Abbott’s Omnilink Elite® Vascular Balloon-Expandable Stent System receives FDA approval

Industry news, News / 7 August 2012 / Abbott

The U.S. FDA has approved the Omnilink Elite® Vascular Balloon-Expandable Stent System…

Abbott logo

Abbott’s XIENCE PRIME™ and XIENCE V® Drug Eluting Stents receive indication in Europe

Industry news, News / 15 May 2012 / Abbott

New indication supported by data from more than 10,000 patients…

Abbott logo

Absolute Pro® Vascular Self-Expanding Stent System receives FDA approval

Industry news, News / 7 March 2012 / Abbott

The U.S. FDA approved the Absolute Pro® Vascular Self-Expanding Stent System…

Abbott logo

Abbott initiates clinical trial to evaluate the Absorb™ bioresorbable vascular scaffold compared to a metallic drug eluting stent

Industry news, News / 8 December 2011 / Abbott

Abbott today announced the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +